Tango Therapeutics Inc.

NASDAQ: TNGX · Real-Time Price · USD
6.79
-0.13 (-1.88%)
At close: Aug 15, 2025, 3:59 PM
6.77
-0.29%
After-hours: Aug 15, 2025, 04:59 PM EDT

Tango Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-38.85M -39.88M -37.67M -29.17M -25.55M -37.91M -30.76M -22.26M -20.71M -28.01M -29.06M -29.05M -24.86M -25.21M -22.05M -19.59M -4.49M -12.11M
Depreciation & Amortization
625K 622K 620K 622K 632K 625K 617K 613K 604K 581K 570K 417K 312K 309K 256K 225K 212K 204K
Stock-Based Compensation
6.57M 7.25M 7.46M 7.18M 7.54M 6.72M 4.88M 4.86M 5.12M 4.22M 3.79M 3.81M 3.42M 3.21M 2.26M 3.43M 1.2M 950K
Other Working Capital
11.65M -11.65M -4.64M -14.82M -3.22M -7.87M -662K -14.06M -8.3M -15.24M -2.94M 130K -8.76M -8.03M -3.72M 1.21M -4.93M -5.52M
Other Non-Cash Items
-14.88M 318K 88K -245K -236K -456K -1.45M 1.67M 24K -12K 417K 584K 335K 415K 404K 309K 310K 300K
Deferred Income Tax
n/a n/a n/a n/a n/a n/a -2.36M 739K -1.77M n/a n/a n/a n/a n/a 0.00 n/a n/a n/a
Change in Working Capital
10.02M -10.02M -7.15M -11.78M -5.99M -6.83M -750K -16.02M -9.51M -11.69M -3.98M 4.62M -10.75M -8.39M 2.23M -5.87M -4.74M -2.96M
Operating Cash Flow
-36.52M -41.7M -36.65M -33.39M -23.61M -37.86M -27.47M -31.14M -24.47M -34.91M -28.27M -19.61M -31.54M -29.66M -16.9M -21.49M -7.52M -13.61M
Capital Expenditures
-624K -51K -124K -115K -320K -195K -226K -16K -664K -620K -1.04M -3.28M -1.81M -1.56M -696K -774K -202K -165K
Cash Acquisitions
n/a n/a n/a n/a n/a n/a -34.08M 56.65M -33.35M -32.17M 11.56M -18.51M -37.3M n/a 32.48K 32.51 -32.51K n/a
Purchase of Investments
-23.94M -47.16M -32.55M -39.47M -48.61M -120.26M -51.02M -156.24M -50.78M -52.53M -93.56M -44.45M -15.92M -54.57M -104.39M -181.86M -66.25M -19.87M
Sales Maturities Of Investments
41.34M 77.81M 84.73M 72.15M 61.63M 109.25M 85.1M 99.59M 84.13M 84.7M 81.99M 62.96M 53.23M 44.41M 59.87M 30.42M 59.83M 40.65M
Other Investing Acitivies
n/a n/a n/a n/a n/a n/a 34.08M -56.65M 33.35M 32.17M -11.56M 18.51M 37.3M -10.16M -32.48K -32.51 32.51K 20.78M
Investing Cash Flow
16.78M 30.6M 52.06M 32.57M 12.7M -11.2M 33.85M -56.66M 32.69M 31.55M -12.61M 15.23M 35.49M -11.72M -45.21M -152.21M -6.63M 20.61M
Debt Repayment
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
581K 2K 969K 2.4M 1.31M 1.26M 1.47M 441K 586K 73K 527K 113K 718K 257K -120K 327.78M -746K 413K
Financial Cash Flow
581K 2K 969K 2.4M 1.31M 42.98M 1.47M 80.28M 586K 73K 527K 113K 718K 257K -120K 327.78M -746K 30.41M
Net Cash Flow
-19.16M -11.1M 16.38M 1.58M -9.6M -6.08M 7.85M -7.52M 8.8M -3.28M -40.34M -4.27M 4.67M -41.13M -62.23M 154.07M -14.89M 37.41M
Free Cash Flow
-37.14M -41.75M -36.77M -33.51M -23.93M -38.05M -27.69M -31.15M -25.14M -35.53M -29.31M -22.89M -33.35M -31.23M -17.6M -22.27M -7.72M -13.78M